Experts in supercritical fluids and nanomedicines

CDMO

StaniPharm is a Contract Development and Manufacturing Organization (CDMO).

Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services.

Our tailored solutions to move your products from idea to market

Tailored drug (nano)particles

We finely control the size and morphology of drug particles. We nanosize your Active Pharmaceutical Ingredients to tackle their poor aqueous solubility.

Botanical extracts

We solve extraction, purification and separation challenges to produce standardized broad spectrum extracts or isolate drug substances.

Polymers and lipids

We purify and fractionate challenging polymers and lipids for demanding medical and pharmaceutical applications.

Nanoformulations

We develop and scale-up the manufacturing of nano-enabled health products: nanoparticles, nanoemulsions...

GMP manufacturing of vaccine nanovectors in StaniPharm's clean rooms

StaniPharm was founded in 2010 but our history goes back much further than that.

With 40+ years of collective experience in supercritical fluids, our 3 founders spun off the Pharmaceutical Business Unit of SEPAREX

2010

First clinical batch of drug nanocrystals using StaniTab® supercritical fluid technology

2014

Design and qualification of an industrial unit for supercritical extraction of cannabis APIs

2015

Winner of the Deloitte In Extenso Technology Fast 50

2016

World's first aseptic supercritical fluid purification of an injectable polymer - Manufacturing of clinical trial materials (ISO 13485 and 13408)

2017

GMP manufacturing of nanoparticles for vaccine formulation

2020